Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
Maria S. Simon, Gara Arteaga-Henríquez, Ahmed Fouad Algendy, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 1-25
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
Gislaine Z. Réus, Luana M. Manosso, João Quevedo, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105425-105425
Closed Access | Times Cited: 35
How Oxidative Stress Induces Depression?
Na Ji, Mengzhu Lei, Yating Chen, et al.
ASN NEURO (2023) Vol. 15
Open Access | Times Cited: 27
Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Adam Gędek, Zofia Szular, Anna Antosik-Wójcińska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3497-3497
Open Access | Times Cited: 19
Recognizing depression as an inflammatory disease: The search for endotypes
Johannes Steffen, Nis Focken, Gürsel Çalışkan
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C205-C212
Closed Access | Times Cited: 6
Lipopolysaccharide preconditioning disrupts the behavioral and molecular response to restraint stress in male mice
Elisa Piton Lovis, Gabriele Cheiran Pereira, Fernanda Tibolla Viero, et al.
Neuroscience (2025) Vol. 567, pp. 281-293
Closed Access
Progress in the application of novel inflammatory indicators in chronic kidney disease
Wei Gao, Xiangyu Wang, Yulin Zou, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
The Genetic Overlap Between Major depressive disorder, White Blood Cell Counts and Interleukin 6
Erik D. Wiström, Kevin S. O’Connell, Elise Koch, et al.
Journal of Affective Disorders Reports (2025), pp. 100889-100889
Open Access
Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysis
Calum D. Moulton, Mantas Malys, Christopher W. P. Hopkins, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 3
Treatment-resistant depression: molecular mechanisms and management
Mayanja Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 3
Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis
Jasper Vöckel, Anna Markser, Lisa Wege, et al.
European Neuropsychopharmacology (2023) Vol. 78, pp. 16-29
Open Access | Times Cited: 7
Pharmacotherapeutic value of inflammatory and neurotrophic biomarkers in bipolar disorder: A systematic review
Paloma Ruiz-Sastre, Carlos Gómez Sánchez-Lafuente, Jaime Martín‐Martín, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111056-111056
Open Access | Times Cited: 2
The Role of Copper Overload in Modulating Neuropsychiatric Symptoms
Mirko Manchia, Pasquale Paribello, Martina Pinna, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6487-6487
Open Access | Times Cited: 2
Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in Major Depressive Disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial
Céline Wessa, J. Janssens, Violette Coppens, et al.
Brain Behavior & Immunity - Health (2024) Vol. 41, pp. 100871-100871
Open Access | Times Cited: 2
Inflammation, Atherosclerosis and Hypertension: The Impact of Depression and Stress on their Complex Relationship
M Coronelli, Francesca Coppi, Anna Vittoria Mattioli
Future Cardiology (2023) Vol. 20, Iss. 1, pp. 27-33
Closed Access | Times Cited: 5
Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review
Evgeni Gusev, Alexey Sarapultsev
Current Pharmaceutical Design (2023) Vol. 30, Iss. 3, pp. 180-214
Closed Access | Times Cited: 5
Early life adversities, psychopathologies and novel pharmacological strategies
Annamaria Cattaneo, Veronica Begni, Valentina Zonca, et al.
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108686-108686
Open Access | Times Cited: 1
The role of immunomodulators in severe mental disorders: future perspectives
Bernhard T. Baune, Sarah E. Fromme
Current Opinion in Psychiatry (2024)
Closed Access | Times Cited: 1
Glutathione alterations in depression: a meta-analysis and systematic review of proton magnetic resonance spectroscopy studies
John Cha, Mitul A. Mehta, Luwaiza Mirza, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 1
Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]
Céline Wessa, Manuel Morrens, Livia De Picker
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 515-517
Open Access | Times Cited: 4
Association of anxiety and depressive symptoms with C-reactive protein in diverse Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Lourdes R. Guerrero, Suzi Hong, Wassim Tarraf, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289833-e0289833
Open Access | Times Cited: 4
Minocycline in depression not responding to first-line therapy: A systematic review and meta-analysis
Muhammad Aaqib Shamim, Subhanwita Manna, Pradeep Dwivedi, et al.
Medicine (2023) Vol. 102, Iss. 45, pp. e35937-e35937
Open Access | Times Cited: 4
Serum TNFα and IL-17A levels may predict increased depressive symptoms: findings from the Shika Study cohort project in Japan
Hirohito Tsuboi, Hiroyuki Sakakibara, Yuuki Minamida-Urata, et al.
BioPsychoSocial Medicine (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Biomarkers of stress resilience: A review
Pasquale Paribello, Igor Branchi, Aurelia Viglione, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104052-104052
Open Access
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study
E. Van Assche, Christa Hohoff, Ecem Su Atil, et al.
Brain Behavior and Immunity (2024)
Open Access
References

Immune system (2024), pp. 471-578
Closed Access
Page 1 - Next Page

Scroll to top